The Impact of Visible Tumor (PI-RADS ≥ 3) on Upgrading and Adverse Pathology at Radical Prostatectomy in Low Risk Prostate Cancer Patients: A Biopsy Core Based Analysis-Reference-Cited by-同舟云学术

The Impact of Visible Tumor (PI-RADS ≥ 3) on Upgrading and Adverse Pathology at Radical Prostatectomy in Low Risk Prostate Cancer Patients: A Biopsy Core Based Analysis

Published:2022-02 Issue:1 Volume:20 Page:e61-e67
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Özkan Arif,Köseoğlu Ersin,Kılıç Mert,Baydar Dilek Ertoy,Sağlıcan Yeşim,Balbay Mevlana Derya,Canda Abdullah Erdem,Kordan Yakup^ORCID,Kiremit Murat Can,Çil Barbaros^ORCID,Tuğcu Volkan,Bakır Barış,Esen Tarık

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference23 articles.

1. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent;Mottet;Eur Urol,2021

2. Accuracy of sampling pi-rads 4-5 index lesions alone by mri-guided in-bore biopsy in biopsy-naive patients undergoing radical prostatectomy;Kilic;Eur Urol Focus,2020

3. Comparison of MR/ltrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer;Siddiqui;JAMA,2015

4. MRI-targeted or standard biopsy for prostate-cancer diagnosis;Kasivisvanathan;N Engl J Med,2018

5. Complications and adverse events of three magnetic resonance imaging-based target biopsy techniques in the diagnosis of prostate cancer among men with prior negative biopsies: results from the future trial, a multicentre randomised controlled trial;Wegelin;Eur Urol Oncol,2019

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of a novel nomogram to avoid unnecessary biopsy in patients with PI-RADS category ≥ 4 lesions and PSA ≤ 20 ng/ml;World Journal of Urology;2024-08-23

2. Can the Briganti 2019 nomogram be modified to predict lymph node metastasis risk in patients with prostate cancer detected with in‐bore biopsy?;International Journal of Urology;2024-08-14

3. The role of PSMA PET/CT to predict upgrading in patients undergoing radical prostatectomy for ISUP grade group 1 prostate cancer;The Prostate;2023-09-03

4. Renaming Grade Group 1 Prostate “Cancer” From a Pathology Perspective: A Call for Multidisciplinary Discussion;Advances in Anatomic Pathology;2023-04-17

5. The role of the size and number of index lesion in the diagnosis of clinically significant prostate cancer in patients with PI-RADS 4 lesions who underwent in-bore MRI-guided prostate biopsy;World Journal of Urology;2023-01-03